Suppr超能文献

颅内椎动脉未破裂夹层动脉瘤血管内重建采用 Pipeline 栓塞装置的长期疗效。

Long-term outcome of endovascular reconstruction with the Pipeline embolization device in the management of unruptured dissecting aneurysms of the intracranial vertebral artery.

机构信息

Department of Radiology, Tuen Mun Hospital, Tuen Mun, China.

出版信息

J Neurosurg. 2012 Apr;116(4):882-7. doi: 10.3171/2011.12.JNS111514. Epub 2012 Jan 20.

Abstract

OBJECT

Use of a flow-diverting device has shown promising short-term results in the management of vertebral artery (VA) dissecting aneurysms, but there is still uncertainty regarding its long-term efficacy and safety. The authors report their initial experience with respect to the potential utility and long-term clinical outcomes of using a flow-diverting device in the treatment of unruptured dissecting VA aneurysms.

METHODS

The authors conducted a retrospective review of all cases of unruptured intracranial VA dissecting aneurysms treated at their institution (Tuen Mun Hospital) with a flow-diverting device. They describe the clinical presentations and angiographic features of the cases and report the clinical outcome (with modified Rankin Scale [mRS] scores) at most recent follow-up, as well as results of the latest angiographic assessment, with particular focus on in-stent patency and side-branch occlusion.

RESULTS

A total of 4 aneurysms were successfully obliterated by using flow-diverting devices alone. Two devices were deployed in a telescoping fashion in each of 2 aneurysms, whereas only 1 device was inserted in each of the other 2 aneurysms. No periprocedural complication was encountered. No patient showed any angiographic evidence of recurrence, in-stent thrombosis, or side-branch occlusion in angiographic reassessment at a mean of 22 months after treatment (range 18-24 months). As of the most recent clinical follow-up (mean 30 months after treatment, range 24-37 months), all patients had favorable outcomes (mRS Score 0).

CONCLUSIONS

Reconstruction using a flow-diverting device is an attractive alternative in definitive treatment of dissecting VA aneurysms, demonstrating favorable long-term clinical and angiographic outcomes and the ability to maintain parent artery and side-branch patency. It is particularly useful in cases with eloquent side-branch or dominant VA involvement.

摘要

目的

在椎动脉(VA)夹层动脉瘤的治疗中,使用血流导向装置已显示出有前景的短期结果,但长期疗效和安全性仍存在不确定性。作者报告了他们在使用血流导向装置治疗未破裂的夹层 VA 动脉瘤方面的初步经验,包括其潜在用途和长期临床结果。

方法

作者对在其机构(屯门医院)接受血流导向装置治疗的所有未破裂颅内 VA 夹层动脉瘤病例进行了回顾性研究。他们描述了病例的临床表现和血管造影特征,并报告了最近随访时的临床结果(采用改良 Rankin 量表[mRS]评分),以及最新血管造影评估的结果,特别关注支架内通畅性和侧支闭塞。

结果

共有 4 个动脉瘤通过单独使用血流导向装置成功闭塞。2 个动脉瘤中每个动脉瘤采用 2 个支架套叠放置,另外 2 个动脉瘤中每个动脉瘤只放置 1 个支架。在围手术期未发生任何并发症。在治疗后平均 22 个月(范围 18-24 个月)的血管造影复查中,没有患者出现血管造影再发、支架内血栓形成或侧支闭塞的证据。截至最近的临床随访(治疗后平均 30 个月,范围 24-37 个月),所有患者的结局均良好(mRS 评分 0)。

结论

使用血流导向装置进行重建是治疗夹层 VA 动脉瘤的一种有吸引力的替代方法,可获得良好的长期临床和血管造影结果,并能维持载瘤动脉和侧支通畅。对于有重要侧支或优势 VA 受累的病例,尤其有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验